BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37602756)

  • 1. Ruthenium(II) polypyridyl complexes with visible light-enhanced anticancer activity and multimodal cell imaging.
    Kang Y; Zhao Y; Wei Y; Zhang Y; Wang Z; Luo Q; Du J; Wang F
    Dalton Trans; 2023 Sep; 52(35):12478-12489. PubMed ID: 37602756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
    Du J; Kang Y; Zhao Y; Zheng W; Zhang Y; Lin Y; Wang Z; Wang Y; Luo Q; Wu K; Wang F
    Inorg Chem; 2016 May; 55(9):4595-605. PubMed ID: 27093574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
    Heinemann F; Karges J; Gasser G
    Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Alkyl Chain Length on the Photophysical, Photochemical, and Photobiological Properties of Ruthenium(II) Polypyridyl Complexes for Their Application as DNA-Targeting, Cellular-Imaging, and Light-Activated Therapeutic Agents.
    Estalayo-Adrián S; Blasco S; Bright SA; McManus GJ; Orellana G; Williams DC; Kelly JM; Gunnlaugsson T
    ACS Appl Bio Mater; 2021 Sep; 4(9):6664-6681. PubMed ID: 35006970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photocytotoxic kinetically stable ruthenium(II)-
    Sayala J; Srivastava E; Kumar P; Shukla N; Kumar A; Patra AK
    Dalton Trans; 2024 Mar; 53(10):4580-4597. PubMed ID: 38349214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
    Fayad C; Audi H; Khnayzer RS; Daher CF
    J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
    Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F
    Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, photophysical, lipophilicity, and in vitro fluorescence studies of mono-, di-, and trinuclear Ru(II) polypyridyl complexes of pyridinyl benzimidazole derivatives.
    Prajith NU; Priyanka PV; Alexander V
    J Biol Inorg Chem; 2022 Apr; 27(3):357-372. PubMed ID: 35262796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, stability, and photoreactivity of thiolato ruthenium polypyridyl complexes: Can cysteine derivatives protect ruthenium-based anticancer complexes?
    van Rixel VH; Busemann A; Göttle AJ; Bonnet S
    J Inorg Biochem; 2015 Sep; 150():174-81. PubMed ID: 26187140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of new ruthenium polypyridyl complexes with potent antitumor activity in vitro.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Sep; 220():117132. PubMed ID: 31146211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.
    Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK
    J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum(II) Terpyridine Anticancer Complexes Possessing Multiple Mode of DNA Interaction and EGFR Inhibiting Activity.
    Li C; Xu F; Zhao Y; Zheng W; Zeng W; Luo Q; Wang Z; Wu K; Du J; Wang F
    Front Chem; 2020; 8():210. PubMed ID: 32411653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release.
    Hufziger KT; Thowfeik FS; Charboneau DJ; Nieto I; Dougherty WG; Kassel WS; Dudley TJ; Merino EJ; Papish ET; Paul JJ
    J Inorg Biochem; 2014 Jan; 130():103-11. PubMed ID: 24184694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cell-impermeable Ru(II) polypyridyl complex as a potent intracellular photosensitizer under visible light irradiation via ion-pairing with suitable lipophilic counter-anions.
    Yan ZY; Chen J; Shao J; Jiao ZQ; Tang TS; Tang M; Sheng ZG; Mao L; Huang R; Huang CH; Zhang ZH; Su HM; Zhu BZ
    Free Radic Biol Med; 2021 Aug; 171():69-79. PubMed ID: 33957221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cytotoxicity, cellular uptake, reactive oxygen species and cell cycle arrest studies of novel ruthenium(II) polypyridyl complexes towards A549 lung cancer cell line.
    Qasim Warraich M; Ghion A; Perdisatt L; O'Neill L; Casey A; O'Connor C
    Drug Chem Toxicol; 2021 May; 44(3):319-329. PubMed ID: 30991856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
    Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
    Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the potential of highly charged Ru(II)- and heteronuclear Ru(II)/Cu(II)-polypyridyl complexes as antimicrobial agents.
    Conti L; Mengoni A; Giacomazzo GE; Mari L; Perfetti M; Fagorzi C; Sorace L; Valtancoli B; Giorgi C
    J Inorg Biochem; 2021 Jul; 220():111467. PubMed ID: 33932708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers.
    Hess J; Huang H; Kaiser A; Pierroz V; Blacque O; Chao H; Gasser G
    Chemistry; 2017 Jul; 23(41):9888-9896. PubMed ID: 28509422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic investigation of the antiproliferative activity of a series of ruthenium terpyridine complexes.
    Karges J; Blacque O; Jakubaszek M; Goud B; Goldner P; Gasser G
    J Inorg Biochem; 2019 Sep; 198():110752. PubMed ID: 31242458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoactivatable Ruthenium Complexes Containing Minimal Straining Benzothiazolyl-1,2,3-triazole Chelators for Cancer Treatment.
    Ballester FJ; Hernández-García A; Santana MD; Bautista D; Ashoo P; Ortega-Forte E; Barone G; Ruiz J
    Inorg Chem; 2024 Apr; 63(14):6202-6216. PubMed ID: 38385171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.